BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr Nephrol. 2011;26:1843-1849. [PMID: 21499946 DOI: 10.1007/s00467-011-1883-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Raaijmakers A, Petit T, Gu Y, Zhang Z, Wei F, Cools B, Jacobs L, Thijs L, Thewissen L, Levtchenko E, Staessen JA, Allegaert K. Design and feasibility of "PREMATurity as predictor of children's Cardiovascular-renal Health" (PREMATCH): A pilot study. Blood Press 2015;24:275-83. [PMID: 26107770 DOI: 10.3109/08037051.2015.1053220] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
2 van Donge T, Allegaert K, Pfister M, Smits A, van den Anker J. Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn. Front Pharmacol 2020;11:610294. [PMID: 33569003 DOI: 10.3389/fphar.2020.610294] [Reference Citation Analysis]
3 Carmody JB, Swanson JR, Rhone ET, Charlton JR. Recognition and reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol. 2014;9:2036-2043. [PMID: 25280497 DOI: 10.2215/cjn.05190514] [Cited by in Crossref: 119] [Cited by in F6Publishing: 51] [Article Influence: 17.0] [Reference Citation Analysis]
4 Pacifici GM. Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure. Paediatr Drugs 2013;15:363-76. [PMID: 23754139 DOI: 10.1007/s40272-013-0031-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
5 Raaijmakers A, Ortibus E, van Tienoven TP, Vanhole C, Levtchenko E, Allegaert K. Neonatal creatinemia trends as biomarker of subsequent cognitive outcome in extremely low birth weight neonates. Early Hum Dev 2015;91:367-72. [PMID: 25919998 DOI: 10.1016/j.earlhumdev.2015.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Allegaert K. Tailored tools to improve pharmacotherapy in infants. Expert Opin Drug Metab Toxicol 2014;10:1069-78. [PMID: 24961300 DOI: 10.1517/17425255.2014.931937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
7 Michelet R, Van Bocxlaer J, Allegaert K, Vermeulen A. The use of PBPK modeling across the pediatric age range using propofol as a case. J Pharmacokinet Pharmacodyn 2018;45:765-85. [PMID: 30298439 DOI: 10.1007/s10928-018-9607-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
8 De Cock RF, Allegaert K, Sherwin CM, Nielsen EI, de Hoog M, van den Anker JN, Danhof M, Knibbe CA. A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates. Pharm Res 2014;31:754-67. [PMID: 24065592 DOI: 10.1007/s11095-013-1197-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
9 Kaguelidou F, Alberti C, Biran V, Bourdon O, Farnoux C, Zohar S, Jacqz-Aigrain E. Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach. PLoS One 2016;11:e0166207. [PMID: 28002471 DOI: 10.1371/journal.pone.0166207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hwang JH, Lee EH, Kim EA. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors. J Korean Med Sci 2015;30 Suppl 1:S88-94. [PMID: 26566363 DOI: 10.3346/jkms.2015.30.S1.S88] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
11 Gong W, Duan Q, Cai Z, Chen C, Ni L, Yan M, Wang X, Cianflone K, Wang DW. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure. Br J Pharmacol 2013;170:1396-409. [PMID: 24032459 DOI: 10.1111/bph.12346] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
12 Allegaert K, van den Anker JN. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol 2015;80:788-95. [PMID: 24862557 DOI: 10.1111/bcp.12430] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
13 Schreuder MF, Bueters RR, Allegaert K. The interplay between drugs and the kidney in premature neonates. Pediatr Nephrol 2014;29:2083-91. [PMID: 24217783 DOI: 10.1007/s00467-013-2651-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
14 Bateman DA, Thomas W, Parravicini E, Polesana E, Locatelli C, Lorenz JM. Serum creatinine concentration in very-low-birth-weight infants from birth to 34-36 wk postmenstrual age. Pediatr Res 2015;77:696-702. [PMID: 25675426 DOI: 10.1038/pr.2015.25] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
15 Smits A, Annaert P, Allegaert K. Drug disposition and clinical practice in neonates: Cross talk between developmental physiology and pharmacology. International Journal of Pharmaceutics 2013;452:8-13. [DOI: 10.1016/j.ijpharm.2012.03.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
16 Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98:462-466. [PMID: 23606713 DOI: 10.1136/archdischild-2013-303688] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
17 Bhongsatiern J, Stockmann C, Yu T, Constance JE, Moorthy G, Spigarelli MG, Desai PB, Sherwin CM. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance? J Clin Pharmacol 2016;56:528-40. [PMID: 26412385 DOI: 10.1002/jcph.650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 van den Anker J, Allegaert K. Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach. Expert Rev Clin Pharmacol. 2012;5:5-8. [PMID: 22142152 DOI: 10.1586/ecp.11.65] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
19 O'Hara K, Wright IM, Schneider JJ, Jones AL, Martin JH. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future. Br J Clin Pharmacol 2015;80:1281-8. [PMID: 26256466 DOI: 10.1111/bcp.12741] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
20 Raaijmakers A, Jacobs L, Rayyan M, van Tienoven TP, Ortibus E, Levtchenko E, Staessen JA, Allegaert K. Catch-up growth in the first two years of life in Extremely Low Birth Weight (ELBW) infants is associated with lower body fat in young adolescence. PLoS One 2017;12:e0173349. [PMID: 28278233 DOI: 10.1371/journal.pone.0173349] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
21 Allegaert K, Smits A, van Donge T, van den Anker J, Sarafidis K, Levtchenko E, Mekahli D. Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions. Front Pediatr 2020;8:366. [PMID: 32850523 DOI: 10.3389/fped.2020.00366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
22 Pacifici GM, Allegaert K. Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics (Sao Paulo) 2012;67:831-7. [PMID: 22892931 DOI: 10.6061/clinics/2012(07)21] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
23 Girardi A, Raschi E, Galletti S, Allegaert K, Poluzzi E, De Ponti F. Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development. Expert Opin Drug Metab Toxicol 2017;13:555-65. [PMID: 28141945 DOI: 10.1080/17425255.2017.1290081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Casteels I, Cassiman C, Van Calster J, Allegaert K. Educational paper: Retinopathy of prematurity. Eur J Pediatr 2012;171:887-93. [PMID: 22052209 DOI: 10.1007/s00431-011-1610-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
25 Illamola SM, Colom H, van Hasselt JG. Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies. Br J Clin Pharmacol 2016;82:793-805. [PMID: 27198625 DOI: 10.1111/bcp.13016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Allegaert K, Kuppens M, Mekahli D, Levtchenko E, Vanstapel F, Vanhole C, van den Anker JN. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method. J Matern Fetal Neonatal Med 2012;25:1678-81. [PMID: 22273037 DOI: 10.3109/14767058.2012.657277] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
28 van Donge T, Allegaert K, Gotta V, Smits A, Levtchenko E, Mekahli D, van den Anker J, Pfister M. Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life. Pediatr Nephrol 2021;36:649-59. [PMID: 32944826 DOI: 10.1007/s00467-020-04749-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Raaijmakers A, Zhang ZY, Levtchenko E, Simons SH, Cauwenberghs N, Heuvel LPVD, Jacobs L, Staessen JA, Allegaert K. Ibuprofen exposure in early neonatal life does not affect renal function in young adolescence. Arch Dis Child Fetal Neonatal Ed 2018;103:F107-11. [PMID: 28615304 DOI: 10.1136/archdischild-2017-312922] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]